Journal of Global Pharma Technology
Volume 12 Issue 02 (2020) Feb. 2020

Introducing Optosonographic Surgical Monitoring Into Clinical Practice

Olga V. Surnina (Unknown)



Article Info

Publish Date
16 Nov 2016

Abstract

Materials and methods: In the period from 2010 to 2017 quite a few people were examined, i.e. a ‘comparison’ group of 200 people and an observation group, i.e. 1667 people. The results were as follows. Optosonographic monitoring in 935 patients (56%) revealed surgical thyroid disease, in 732 patients (44%) revealed a surgical pathology of the mammary glands. Among the identified neoplasms, 741 (79%) were benign ones, and 194 (21%) were malignant ones. The number of patients with mammary neoplasms was 732 patients. Of these, 634 were benign ones (87%) and 95 were malignant ones (13%). Results: The sensitivity in the differential diagnosis by optosonographic method of benign thyroid neoplasms is increased from 63% to 95%, malignant neoplasms from 66% to 96%. Reliability increase from 60% to 98% for the diagnosis of benign breast neoplasms, for malignant ones from 37% to 98%. This allows the use of non-invasive optosonographic monitoring to verify the diagnosis.Keywords: Optosonographic method, Implantation, Mammary gland, Thyroid gland.

Copyrights © 2020






Journal Info

Abbrev

jgpt

Publisher

Subject

Medicine & Pharmacology

Description

ournal of Global Pharma Technology is a monthly, open access, Peer review journal of Pharmacy published by JGPT Journal publishes peer-reviewed original research papers, case reports and systematic reviews. The journal allows free access to its contents, which is likely to attract more readers and ...